Introduction {#S1}
============

Endoplasmic reticulum (ER) is a membrane-bound organelle found throughout the cytoplasm of all eukaryotic cells. It typically comprises more than half of the total animal cell membranes ([@B2]), or 35% of cytoplasmic volume at any one time ([@B372]). Light and electron microscopy (EM), and membrane dye labeling, suggest that uniquely among organelles, the ER appears pervasive and continuous throughout cells, including neurons ([@B367]; [@B356]; [@B407]; [@B411]) ([Figure 1](#F1){ref-type="fig"}). Physically connected to the nuclear envelope, and sharing with it a common lumen, ER includes rough and smooth ER domains. The first is called "rough" due to the density of ribosomes on its surface, which are involved in synthesis of proteins for export from the cytosol. Rough ER is found mainly around the nucleus, organized in a network of membrane sheets that envelop a lumen with a constant distance between sheets, and interconnected by spiral ramps ([@B355]). Smooth ER, with few ribosomes, is found in peripheral parts of the cell, as a network of interconnected cylindrical tubules, with occasional and irregularly spaced sheets (with a constant lumen size like rough ER) or cisternae with a larger and less regularly shaped lumen. This variability in ER morphology influences ER function. Tubules are regions for lipid synthesis and contacts with other organelles; cisternae, with a larger lumen, in addition have more capacity for calcium storage ([@B311]). Therefore, the extent and spatial distribution of different ER morphologies depends on cell type and cell demands.

![Endoplasmic reticulum (ER) distribution in neuronal cells. **(A)** ER network (blue) is continuously distributed throughout the cytosol (orange) in neurons, including cell body, axon, presynaptic terminals, and most dendrites. **(B)** Since ER forms a continuous structure that follows the shape of the cell, it has been termed "a neuron within a neuron" ([@B28], [@B29]). In the cell body, continuous with the nuclear envelope, is found rough ER, characterized by its sheet-like morphology and the presence of ribosomes (dark blue points) attached to the ER membrane (magnified detail on the left). Peripheral ER (smooth) includes cortical ER in the cell body and dendritic and axonal ER, and is mainly formed by a network of interconnected tubules, with occasional sheets or cisternae (magnified detail on the right). Tubulation of ER membrane is physically promoted by ER-shaping proteins, which share a characteristic intramembrane domain inserted in the cytosolic face of the ER membrane (magnified detail on the bottom right).](fnins-14-00048-g001){#F1}

Rough ER is specialized for protein export from the cytosol. Most exported proteins have an N-terminal signal sequence that directs them to rough ER, where they are co-translationally transported across the ER membrane, folded in the ER lumen, and sorted for transport to another intracellular membrane compartment or the extracellular secretory pathway. Type I transmembrane proteins, with an extracellular or luminal N-terminus, follow similar pathways, but remain embedded in the ER membrane, due to an internal transmembrane domain that prevents the rest of the protein from being exported ([@B311]). Smooth ER, on the other hand, plays important roles in both lipid ([@B164]) and glucose ([@B220]; [@B238]) metabolism, as well as in Ca^2+^ dynamics ([@B311]).

Until recently, axonal ER received scant attention since its characterization by electron microscopy some four decades ago e.g., [@B367], partly due to the lack of molecular markers and the difficulty of resolving it using conventional osmium staining in thin EM sections. However, both these hurdles have recently been overcome e.g., [@B382] and [@B411]. Axonal ER has the characteristics of a largely smooth tubular ER network, which must share many of its functions with the better characterized equivalent network in non-neuronal cells, but with specialized roles and constraints that reflect the long and narrow dimensions of axons. In this review, we wish to focus on the behavior and function of axonal ER, drawing both on work in axons, but also examining how our broader knowledge of the role of smooth tubular ER might apply to neurons, particularly axons. As background to our review, we have summarized proteins with roles related to tubular ER function, and which of them have been observed in axons ([Table 1](#T1){ref-type="table"}).

###### 

Functional classification of tubular ER-related proteins and localization in axons.

  ***Protein***                                      ***Function***                                                                                                                                                                                                                                                                     ***Axonal localization***
  -------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------
  **Tubular ER Morphogenesis**                                                                                                                                                                                                                                                                                                          
  ARL6IP1                                            ER tubulation ([@B412]; **[@B87]**)                                                                                                                                                                                                                                                Yes ([@B87])
  Ataxin-2                                           Tubular ER network organization (**[@B76]**)                                                                                                                                                                                                                                       Yes ([@B280])
  ATLs                                               Homotypic membrane fusion between ER tubules ([@B156]; **[@B252]**)                                                                                                                                                                                                                Yes ([@B425]; [@B196]; [@B260]; [@B21]; [@B182])
  INPP5K                                             ER tubulation (**[@B87]**)                                                                                                                                                                                                                                                         Yes ([@B87])
  Lunapark                                           Stabilization of three-way junctions between ER tubules ([@B57], [@B56])                                                                                                                                                                                                           Yes ([@B40])
  MCTP2/Pex30                                        ER tubulation ([@B167], [@B168])                                                                                                                                                                                                                                                   Yes ([@B116])
  MFN2                                               Control of ER network continuity ([@B71])                                                                                                                                                                                                                                          Yes ([@B45])
  Protrudin                                          ER tubulation ([@B52])                                                                                                                                                                                                                                                             Yes ([@B257])
  Rab10                                              Tubular ER network organization ([@B97])                                                                                                                                                                                                                                           Yes ([@B79]; [@B390]; [@B300]; [@B410])
  Rab18                                              Tubular ER network organization ([@B118])                                                                                                                                                                                                                                          Unknown
  Rab3GAPs                                           Tubular ER network organization by targeting Rab18 to the ER ([@B118])                                                                                                                                                                                                             Yes ([@B237])
  REEPs                                              ER tubulation ([@B383]; **[@B19]**; **[@B411]**)                                                                                                                                                                                                                                   Yes ([@B260]; [@B411])
  RTNs                                               ER tubulation ([@B383]; **[@B253]**; [@B281]; [@B387]; **[@B411]**)                                                                                                                                                                                                                Yes ([@B250]; [@B253]; [@B80]; [@B200]; [@B282]; [@B411])
  VAPA/B                                             Control of ER network continuity (**[@B207]**)                                                                                                                                                                                                                                     Yes ([@B263]; [@B178]; [@B121]; [@B207])
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER Motility and Association With MTs**                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                        
  P180                                               MT stabilization from ER tubules (**[@B102]**)                                                                                                                                                                                                                                     Yes ([@B102])
  p600                                               MT interaction and stabilization, and interaction with ER tubules (**[@B322]**)                                                                                                                                                                                                    Yes ([@B322])
  Rab10                                              Regulation of ER tubules extension along MTs ([@B97])                                                                                                                                                                                                                              Yes ([@B390]; [@B300]; [@B79]; [@B410])
  REEP1                                              Interaction between tubular ER and MTs ([@B260])                                                                                                                                                                                                                                   Yes ([@B260])
  RTNs                                               Constriction of ER tubules ([@B98])                                                                                                                                                                                                                                                Yes ([@B250]; [@B253]; [@B80]; [@B411])
  Sec61β                                             Subunit of the Sec61 translocon complex that interacts with MTs ([@B427])                                                                                                                                                                                                          Yes ([@B341]; [@B102]; [@B207])
  Spastin                                            ATP-dependent severing of MTs (**[@B316]; [@B365];** [@B288]; [@B260])                                                                                                                                                                                                             Yes ([@B365]; [@B260])
  STIM1                                              MT-mediated transport of ER tubules by interacting with EB1 ([@B125]; [@B261])                                                                                                                                                                                                     Yes ([@B231]; [@B321]; [@B73]; [@B261])
  VAPA/B                                             Regulation of ER tubules dynamics (**[@B207]**)                                                                                                                                                                                                                                    Yes ([@B263]; [@B178]; [@B121]; [@B207])
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER Turnover**                                                                                                                                                                                                                                                                                                               
                                                                                                                                                                                                                                                                                                                                        
  ATL3                                               Turnover of ER tubules via autophagy by interacting with the ATG8 family protein GABARAP ([@B55])                                                                                                                                                                                  Yes ([@B21]; [@B182])
  RTN3                                               Turnover of ER tubules via autophagy by interacting with ATG8 family proteins LC3s/GABARAPs ([@B127])                                                                                                                                                                              Yes ([@B184]; [@B80])
  TEX264                                             Turnover of tubular ER three-way junctions via autophagy by interacting with ATG8 family proteins LC3s/GABARAPs ([@B10]; [@B62])                                                                                                                                                   Unknown
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER-Endosome MCSs**                                                                                                                                                                                                                                                                                                          
                                                                                                                                                                                                                                                                                                                                        
  Spastin                                            Endosomal tubule fission at ER-endosomes MCSs (**[@B6], [@B5]**)                                                                                                                                                                                                                   Yes ([@B365]; [@B260])
  Protrudin                                          ER-late endosomes tethering with VAPA ([@B279])                                                                                                                                                                                                                                    Yes ([@B257])
  PTP1B                                              Phosphorylation of EGFR at ER-endosomes MCSs ([@B92])                                                                                                                                                                                                                              Unknown
  Vps13C                                             Lipid transfer protein that mediates ER-endosome/lysosomes contacts ([@B187])                                                                                                                                                                                                      Unknown
  Osbp-related proteins                              Lipid transfer protein ORP1L mediates ER-late endosomes tethering by interacting with Rab7 and VAP ([@B286]) Lipid transfer protein Osbp associates with ER-endosomes MCSs ([@B86]) Lipid transfer protein ORP5 mediates ER-endosome tethering by interacting with NPC1 ([@B88])   Yes ([@B213])
  PDZD8                                              Rab7-dependent interaction between ER and late endosomes/lysosomes ([@B130])                                                                                                                                                                                                       Unknown
  VAPA/B                                             ER-endosomes tethering by interacting with SNX2 and lipid transfer protein Osbp ([@B86]) ER-late endosomes tethering via Rab7 and lipid transfer protein ORP1L ([@B286]), Rab7 and protrudin ([@B279]), or lipid transfer protein STARD3 ([@B7]; [@B397])                          Yes ([@B263]; [@B178]; [@B121]; [@B207])
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER-Mitochondria MCSs**                                                                                                                                                                                                                                                                                                      
                                                                                                                                                                                                                                                                                                                                        
  grp75                                              Chaperone that mediates the interaction between IP3R and VDAC at ER-mitochondria MCSs ([@B345]; **[@B151]; [@B195]**)                                                                                                                                                              Yes ([@B399]; [@B195])
  IP3R                                               Ca^2+^-release channel receptor that promotes ER-mitochondria tethering by interacting with VDAC ([@B47]; **[@B27]**; [@B16]; **[@B195]**)                                                                                                                                         Yes ([@B348]; [@B322]; [@B282]; [@B195])
  MFN2                                               ER-mitochondria tethering ([@B71])                                                                                                                                                                                                                                                 Yes ([@B45])
  Osbp-related proteins                              Lipid transfer proteins ORP5 and ORP8 associates with ER-mitochondria MCSs ([@B287])                                                                                                                                                                                               Yes ([@B213])
  REEP1                                              Formation of ER-mitochondria MCSs ([@B205])                                                                                                                                                                                                                                        Yes ([@B260])
  PDZ8                                               ER-mitochondria tethering (**[@B146]**)                                                                                                                                                                                                                                            Unknown
  SigR1                                              Chaperone that promotes IP3R-VDAC interaction at ER-mitochondria MCSs by stabilizing IP3R ([@B138])                                                                                                                                                                                Yes ([@B275])
  VAPA                                               Interaction with the lipid transfer protein Vps13A at ER-mitochondria MCSs ([@B414])                                                                                                                                                                                               Yes ([@B178]; [@B207])
  VAPB                                               ER-mitochondria tethering by interacting with PTPIP51 ([@B74]; [@B338]; **[@B121]**)                                                                                                                                                                                               Yes ([@B121]; [@B207])
  Vps13A                                             Lipid transport protein that interact with VAPA at ER-mitochondria MCSs ([@B187]; [@B414])                                                                                                                                                                                         Unknown
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER-PM MCSs**                                                                                                                                                                                                                                                                                                                
                                                                                                                                                                                                                                                                                                                                        
  E-Syts                                             Ca^2+^-dependent lipid transfer protein at ER-PM MCSs ([@B302]; [@B415])                                                                                                                                                                                                           Yes ([@B175]; [@B176])
  JPHs                                               ER-PM tethering (reviewed in **[@B189]**)                                                                                                                                                                                                                                          Unknown
  Osbp-related proteins                              Lipid transfer protein Osh3 interact with VAP ([@B336]) and Sec22b ([@B266]) at ER-PM MCSs Lipid transfer proteins ORP5 and ORP8 associates with ER-PM MCSs ([@B65]) Lipid transfer protein ORP3 interact with VAPA at ER-PM MCSs ([@B394])                                        Yes ([@B213])
  Sec22b                                             ER-PM tethering by interacting with Syntaxin1 **([@B266]**) Interaction with lipid transfer proteins Osh2 and Osh3 ([@B266])                                                                                                                                                       Yes ([@B266])
  SigR1                                              Chaperone that attenuates of STIM1-Orai1 interaction at ER-PM MCSs by associating with STIM1 ([@B334])                                                                                                                                                                             Yes ([@B275])
  STIM1                                              Ca^2+^ sensor that controls of the store operated Ca^2+^ entry (SOCE) from the extracellular medium into the ER by interacting with the PM Ca^2+^ channel Orai1 (reviewed in [@B49]) Regulation of PM Ca^2+^ uptake (**[@B73]**)                                                   Yes ([@B231]; [@B321]; **[@B73]; [@B261]**)
  STIM2                                              Control of SOCE in neurons (**[@B24]**)                                                                                                                                                                                                                                            Unknown
  TMEM24                                             Lipid transfer protein with Ca^2+^-dependent localization at ER-PM MCSs (**[@B342]**)                                                                                                                                                                                              Yes ([@B342])
  VAPA/B                                             ER-PM tethering by interacting with Kv2 potassium channels ([@B166]) or Osbp-related lipid transfer proteins ([@B336]; [@B266]; [@B65])                                                                                                                                            Yes ([@B263]; [@B178]; [@B121]; [@B207])
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER Association with LDs/Peroxisomes**                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                                                                                                                                        
  ATL1                                               Regulation of LDs size ([@B179])                                                                                                                                                                                                                                                   Yes ([@B425]; [@B260])
  FATP1                                              Regulation of LDs growth by interacting with DGAT2 at ER-LDSs interface ([@B409])                                                                                                                                                                                                  Unknown
  LDAH                                               Regulation of LDs growth ([@B123])                                                                                                                                                                                                                                                 Yes ([@B411])
  MCTP2/Pex30                                        LD and peroxisome biogenesis ([@B168])                                                                                                                                                                                                                                             Yes ([@B116])
  NRZ complex                                        Part of the Rab18-NRZ/SNARE complex, which mediates ER-LD tethering and LD growth ([@B408])                                                                                                                                                                                        Unknown
  Rab18                                              LDs growth by ER-LDs tethering ([@B222]; [@B254]; [@B408])                                                                                                                                                                                                                         Unknown
  Rab3GAPs                                           ER-LDs tethering and LDs growth by activating and targeting Rab18 ([@B408])                                                                                                                                                                                                        Yes ([@B237])
  REEP1                                              Regulation of LDs size ([@B101])                                                                                                                                                                                                                                                   Yes ([@B260])
  Seipin                                             Determination of the site of LD formation and facilitation of lipid transfer from ER to LDs ([@B297])                                                                                                                                                                              Unknown
  Spastin                                            Regulation of LDs size (**[@B258]**)                                                                                                                                                                                                                                               Yes ([@B365]; [@B260])
  Syntaxin14                                         Regulation of LDs growth at ER-LDs contacts ([@B70])                                                                                                                                                                                                                               Unknown
  SNAREs                                             Part of the Rab18-NRZ/SNARE complex, which mediates ER-LD tethering and LD growth ([@B408])                                                                                                                                                                                        Unknown
  TBC1D20                                            LDs growth ([@B243]; [@B204])                                                                                                                                                                                                                                                      Unknown
  VAPB                                               ER-peroxisomes tethering by interacting with ACBD5 ([@B67])                                                                                                                                                                                                                        Yes ([@B121]; [@B207])
  Vps13A                                             Lipid transfer protein that interact with VAPA at ER-LDs contacts ([@B187]; [@B414])                                                                                                                                                                                               Unknown
  Vps13C                                             Lipid transfer protein that mediates ER-LDs contacts ([@B187])                                                                                                                                                                                                                     Unknown
                                                                                                                                                                                                                                                                                                                                        
  **Tubular ER Ca^2+^ Uptake/Release**                                                                                                                                                                                                                                                                                                  
                                                                                                                                                                                                                                                                                                                                        
  IP3R                                               Ca^2+^-induced Ca^2+^ release to the cytosol ([@B340]; **[@B289]**)                                                                                                                                                                                                                Yes ([@B348]; [@B322]; [@B282]; [@B195])
  RyR                                                Ca^2+^-induced Ca^2+^ release to the cytosol ([@B217]; [@B382])                                                                                                                                                                                                                    Yes ([@B171]; [@B323])
  SERCA                                              ATPase pump that mediates ER Ca^2+^ uptake from the cytoplasm (reviewed in: [@B42]; [@B50])                                                                                                                                                                                        Yes ([@B225])
  SPoCK/ATP2C                                        ATPase pump that may mediate ER Ca^2+^ uptake from the cytoplasm ([@B333])                                                                                                                                                                                                         Unknown

Members of the same family protein are shown in the same row when they are generally related with the same function (for example RTNs in tubular ER morphogenesis); in the "

Function

" column, only the function related with the corresponding category is indicated. Bold type indicates evidences reported in neurons; due to their main importance in rough ER and/or non-neuronal cells, several ER-related functional categories have been omitted, including lipid and glucose synthesis, ER-Golgi interaction and communication, autophagosomes formation, and UPR.

Roles of Endoplasmic Reticulum {#S2}
==============================

ER and Lipid Metabolism {#S2.SS1}
-----------------------

The majority of phospholipids, sterols, sphingolipids, and neutral lipids are synthesized in smooth ER and distributed from there to other cellular compartments. Controlled trafficking of these lipids from/to ER is required to maintain the lipid composition of membranes such as mitochondrial or plasma membrane (PM) ([@B100]; [@B236]). Two different transport mechanisms mediate the transfer of lipids between ER and other cellular organelles: vesicular transport is dependent on membrane budding and fusion via the vesicular transport machinery, whereas non-vesicular lipid transport is mediated by ER membrane contact sites (MCSs) with other organelles ([Figure 2](#F2){ref-type="fig"}). In addition, biogenesis of lipid droplets (LDs) (for storage of sterols and triglycerides) and peroxisomes (involved in lipid decomposition through β-oxidation) initiates in the ER. LDs form initially in the ER lipid bilayer, and bud from the ER membrane as they grow. Although it is not still clear how sites of LD formation are determined, some of the ER proteins associated with them have been identified (e.g., seipin) ([@B346]; [@B296], [@B297]) or Syntaxin14 ([@B70]). These and other proteins, which tether MCS between ER and LDs (discussed below), and control fatty-acid-induced droplet growth, may have roles in determining the sites of nascent LDs. Similarly, peroxisome biogenesis also seems to originate at specific ER domains. In yeast, both peroxisomes and LDs form and remain associated with the same ER subdomains, which contain Pex30 protein ([@B167], [@B168]), suggesting a link between LD and peroxisome biogenesis at the ER membrane. Although the existence of LDs in neurons has been debated, there is some evidence for their presence, including in axons (reviewed in [@B264]).

![Tubular ER membrane contact sites (MCSs). Tubular ER membrane forms contacts with other membranes in the cell, including plasma membrane (PM), Golgi, mitochondria, endosomes, lipid droplets (LDs) and peroxisomes. Axonal ER **(bottom)** also contains MCSs, except with Golgi, due to its absence in axons. ER MCSs can regulate fission of some of the tethered organelles, such as endosomes and mitochondria (dotted circles). ER MCSs **(top right)** are formed by interactions between ER membrane proteins and proteins found in the other cellular membranes (tethering). This keeps both membranes close enough to allow transfer of lipids and Ca^2+^. Depending on the specific channels localized at each MCS (see main text for details), Ca^2+^ can be released from ER lumen to the other compartment (red) or from other compartment to ER lumen (represented in blue). In both scenarios, Ca^2+^ is released locally to the intramembrane space and then taken up by the acceptor compartment. ER MCSs also mediate non-vesicular and bidirectional transport of lipids, which are shuttled between membranes by lipid transfer proteins (green).](fnins-14-00048-g002){#F2}

ER and Glucose Metabolism {#S2.SS2}
-------------------------

Intracellular glucose is phosphorylated to glucose-6-phosphate (G6P) to be used in metabolism and produce ATP. In tissues like liver, G6P is taken up from cytosol into the ER and dephosphorylated there by G6Pase-α to be returned to cytosol when necessary. Deficiency of G6Pase-α causes glycogen storage disease ([@B64]). Another G6Pase isozyme, G6Pase-β, is required in astrocytes for glucose storage in their ER lumen. Knockdown of G6Pase-β causes reduction not only of glucose accumulation, but also of Ca^2+^ regulation, and ATP production in the ER of astrocytes. It has been proposed that ER may serve as a glucose intracellular highway. G6Pase-β would facilitate accumulation of glucose to the ER lumen, where it would be free to diffuse and be protected from further metabolism, until returning to the cytosol through ER glucose transporters, and being phosphorylated to G6P to enter glycolysis ([@B238]). However, it has recently been argued that glucose transport through the ER is too slow (around 550--3,700 times lower than glucose consumption) to be quantitatively relevant for nutrient delivery ([@B84]), and so the physiological role of glucose in the ER lumen is not fully resolved.

ER and Calcium Dynamics {#S2.SS3}
-----------------------

Release and re-uptake of Ca^2+^ to/from the cytosol mediate initiation and termination of many cellular responses to signals. ER is a major calcium store and manages Ca^2+^ homeostasis by either behaving as a local Ca^2+^ sink, or a store that releases Ca^2+^ to other cellular compartments ([@B278]), controlling processes such as mitochondrial homeostasis and function ([@B41]). ER can buffer excess presynaptic cytosolic Ca^2+^ during repetitive firing, by uptake via the SERCA calcium ATPase ([@B298]) or potentially also the SPoCk ATPase ([@B333]). Conversely it can also supply Ca^2+^ to the cytosol via channels including inositol tris-phosphate receptors (IP3R) or ryanodine receptors (RyR) (reviewed by [@B289]). A specific role of ER Ca^2+^ has been recently shown in mammalian neurons, where at presynaptic terminals, ER luminal Ca^2+^ can promote PM Ca^2+^ uptake via the ER Ca^2+^ sensor STIM1, a process required for presynaptic Ca^2+^ flux and exocytosis ([@B73]). Depletion of either the vesicle-associated membrane protein-associated proteins A (VAPA) and B (VAPB), which are ER membrane receptors, or the cytoplasmic VAP-associated protein Secernin-1 (SCRN1), reduces presynaptic Ca^2+^ influx and synaptic vesicle cycling ([@B207]). Also, in *Drosophila* neurons, the ER-resident Ca^2+^ sensor MCTP (multiple C2 domain and transmembrane region protein) promotes release of synaptic vesicles ([@B116]). Therefore, maintenance of ER Ca^2+^ appears to be crucial for proper synaptic function.

A continuous ER network can also support regional or long-distance Ca^2+^ signaling or homeostasis. Ca^2+^ signals can propagate through the cytosol by Ca^2+^-induced Ca^2+^ release from ER, and thus mediate regional and/or global communication within the cell, analogous to but slower than action potential propagation in the PM. Ca^2+^-induced Ca^2+^ release can be mediated by IP3R or RyR receptors, and be potentiated by elevated cytosolic Ca^2+^ ([@B340]; [@B289]). We know little of the occurrence or roles of propagating Ca^2+^ waves in axons, but a few cases are known. For example, a propagating elevation of cytosolic Ca^2+^ is seen after axonal injury in the early stages of Wallerian degeneration ([@B377]). A back-propagating Ca^2+^ wave, which depends on ER Ca^2+^ stores, is also required for the regenerative response to axon injury in dorsal root ganglion (DRG) neurons ([@B63]). Long-range Ca^2+^ waves also play a role in inhibitory signaling among outgrowing neurites to ensure that only a single neurite will form an axon, although a role for ER in this has not been shown ([@B347]). All these are situations in which a local event must be communicated to induce responses in other parts of the cell or axon, and where ER continuity can potentially underpin this communication.

The ER lumen can also act as an intracellular highway for Ca^2+^, allowing "Ca^2+^ tunneling". When luminal Ca^2+^ is released to the cytosol, it must be replenished. The fastest route for replenishment across significant intracellular distances is diffusion through the ER lumen, where there is relatively little Ca^2+^ buffering, leaving Ca^2+^ free to diffuse throughout the lumen of the ER network. This has been shown in non-neuronal cells, including pancreatic acinar cells, *Xenopus* oocytes (reviewed in [@B265]) and HeLa cells ([@B68]), but has not been investigated in neurons.

Axonal ER {#S3}
=========

Presynaptic terminals can lie up to 1 m from the cell body in human neurons. How can axons mediate communication, and be physically maintained, across this distance? Action potentials at the PM carry long-range signals, and the microtubule (MT) network transports physical cargoes ([@B148]). A third potential channel for communication along axons is ER, which appears physically continuous throughout neurons ([@B367]; [@B356]; [@B407]; [@B411]) ([Figure 1](#F1){ref-type="fig"}), and has therefore been termed a "neuron within a neuron" ([@B28], [@B29]).

An important role for tubular ER is also implied by the genetics of some neurological disorders ([Table 2](#T2){ref-type="table"}). For instance, mutations in proteins that regulate tubular ER organization are causative for hereditary spastic paraplegia (HSP) and other axonopathies ([@B159]; [@B202]). Gradual accumulation of abnormally clustered tubular ER is also found in areas surrounding amyloid plaques in Alzheimer's disease (AD) brains ([@B314]). Mutation of proteins associated with membrane contacts between ER and mitochondria can also cause diverse neurological defects, including AD, amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD) or Charcot-Marie-Tooth disease (CMT) ([@B25]). To understand the impact of axonal ER in neurodegeneration, it is first essential to understand how its organization and dynamics are regulated, and the consequences of disrupting these processes.

###### 

Tubular ER-related proteins associated with neurological disorders.

  ***Protein***    ***Roles on/from tubular ER***                                                                                ***Reported phenotypes in axons***                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ***Neurological disorders associated***
  ---------------- ------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  ARL6IP1          Tubular ER morphogenesis                                                                                      KD: ER fragmentation and disrupted mitochondrial network organization at presynaptic terminals ([@B107])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **HSP** ([@B247]; [@B384])
  Ataxin-2         Tubular ER morphogenesis                                                                                      KD: short and bulged neurites ([@B76])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     **ALS** ([@B95]) **SCA** ([@B276])
  ATL1             Tubular ER morphogenesis LDs growth regulation                                                                KD: Reduced axon growth ([@B426]) \*KD: Decreased spontaneous release; impaired anterograde transport ([@B72]); impaired regeneration ([@B200]; [@B282]) \*LOF: Fragmented presynaptic ER; Decreased evoked transmitter release ([@B341]); increased number of presynaptic terminals ([@B196]) \*OE: Decreased spontaneous release; reduced anterograde transport ([@B72]); Decreased evoked transmitter release ([@B341])                                                                                                                                                                 **HSN** ([@B128]) **HSP** ([@B421])
  ATL3             Tubular ER morphogenesis Autophagy-mediated tubular ER turnover                                               LOF: Decreased mitochondrial number ([@B182]) LOF: Impaired neurite outgrowth ([@B21]) \*KD: Decreased spontaneous release; reduced anterograde transport ([@B72]); impaired regeneration ([@B200]; [@B282]) \*LOF: Fragmented presynaptic ER; Decreased evoked transmitter release ([@B341]); increased number of presynaptic terminals ([@B196]) \*OE: Decreased spontaneous release; reduced anterograde transport ([@B72]); Decreased evoked transmitter release ([@B341])                                                                                                             **HSN** ([@B106]; [@B180])
  BNIP1            Tubular ER morphogenesis ER-LDs tethering                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                **ALS** ([@B172])
  INPP5K           Tubular ER morphogenesis                                                                                      OE: Enhanced neurite outgrowth ([@B105])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **Cognitive impairment** ([@B396])
  IP3R             ER-Mitochondria tethering ER-Ca^2+^ transfer to mitochondria Ca^2+^ release                                   LOF/KD: decreased axon degeneration ([@B382]; [@B251])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     AD ([@B61]) **Gillespie syndrome** ([@B117]) HD ([@B351]) HIV-associated sensory neuropathy ([@B149]) **SCA** ([@B374])
  JPH1             ER-PM tethering                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          **CMT** ([@B272])
  JPH3             ER-PM tethering                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          **HD-like 2** ([@B150])
  Lunapark         Tubular ER morphogenesis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 **Neurodevelopmental disorder with epilepsy and corpus callosum hypoplasia** ([@B40])
  MCTP2            Tubular ER morphogenesis LDs and peroxisomes biogenesis                                                       LOF: Decreased presynaptic release probability and extracellular \[Ca^2+^\]-sensitive expression of presynaptic homeostatic plasticity ([@B116])                                                                                                                                                                                                                                                                                                                                                                                                                                           **Bipolar disorder** ([@B85]; [@B312]) **PD** ([@B191])
  MFN2             Tubular ER morphogenesis ER-Mitochondria tethering                                                            LOF: impaired both anterograde and retrograde mitochondrial transport ([@B230]); synaptic loss ([@B386]); axon degeneration and presynaptic mitochondrial clustering ([@B424])                                                                                                                                                                                                                                                                                                                                                                                                             **CMT** ([@B428]) PD ([@B268]) AD ([@B391])
  NAG              ER-LDs tethering                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         **Optic nerve atrophy** ([@B215])
  p600             MT- and ER-interacting protein                                                                                KD: impaired neurite extension and decreased ER accumulation at the leading edge of migrating axons ([@B322])                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **Episodic ataxia** ([@B66]) PD ([@B419])
  PTP1B            Dephosphorylation of the endosome protein EGFR                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           AD ([@B262]; [@B381])
  Rab10            Tubular ER morphogenesis ER movement along MTs                                                                KD: Impaired trafficking of membrane precursor vesicles during axon growth ([@B390]; [@B79]; [@B410]) KD/LOF/OE: impaired dense core vesicles secretion ([@B300])                                                                                                                                                                                                                                                                                                                                                                                                                          AD ([@B285])
  Rab18            Tubular ER morphogenesis ER-LDs tethering                                                                     KD: impaired neurite outgrowth ([@B406]) LOF: axon degeneration ([@B59]); disorganized cytoskeleton and accumulation of MTs at the presynaptic terminals ([@B48])                                                                                                                                                                                                                                                                                                                                                                                                                          **WARBM** ([@B23])
  Rab3GAP1         Tubular ER morphogenesis ER-LDs tethering                                                                     LOF: inhibited Ca^2+^-dependent neurotransmitter release ([@B295]); blocked synaptic homeostatic response ([@B237])                                                                                                                                                                                                                                                                                                                                                                                                                                                                        **WARBM** ([@B3])
  Rab3GAP2         Tubular ER morphogenesis ER-LDs tethering                                                                     KD: impaired neurite outgrowth ([@B406])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   **HSP** ([@B247]) Martsolf syndrome ([@B4]) **WARBM** ([@B38])
  REEP1            Tubular ER morphogenesis ER-Mitochondria tethering ER-MTs interaction LDs growth regulation                   LOF: impaired neurite outgrowth ([@B205]); axon degeneration ([@B19]); large lysosomes ([@B5]) OE: neuritic degeneration ([@B205]) \*LOF: partial loss of ER at distal regions ([@B411])                                                                                                                                                                                                                                                                                                                                                                                                   **HSP** ([@B429]) **Spinal CMT** ([@B20])
  REEP2            Tubular ER morphogenesis                                                                                      \*LOF: partial loss of ER at distal regions ([@B411])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      AD ([@B314]) **HSP** ([@B99])
  REEP5            Tubular ER morphogenesis                                                                                      \*LOF: partial loss of ER at distal regions ([@B411])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      AD ([@B314])
  RTN2             Tubular ER morphogenesis                                                                                      \*KD: partial loss of ER and MTs at distal regions; increased size and reduced number of mitochondria at presynaptic terminals ([@B253]) \*LOF: partial loss of ER and occasional network discontinuities at distal regions; impaired anterograde transport ([@B411])                                                                                                                                                                                                                                                                                                                      **HSP** ([@B233])
  RTN3             Tubular ER morphogenesis Autophagy-mediated tubular ER turnover                                               OE: reduced anterograde transport ([@B318]; [@B80]); ER clustering; reduced size and increased number of mitochondria ([@B314]) \*KD: partial loss of ER and MTs at distal regions; increased size and reduced number of mitochondria at presynaptic terminals ([@B253]) \*LOF: partial loss of ER and occasional network discontinuities at distal regions; impaired anterograde transport ([@B411])                                                                                                                                                                                      AD ([@B314]) Diabetes-induced neuropathy ([@B420])
  RTN4             Tubular ER morphogenesis                                                                                      LOF/KD: enhanced regeneration (associated with the inhibition of RTN4 in oligodendrocytes) ([@B54]; [@B124]; [@B370]) LOF: reduced regeneration (associated with inhibition of RTN4 in neurons) ([@B370]) \*KD: partial loss of ER and MTs at distal regions; increased size and reduced number of mitochondria at presynaptic terminals ([@B253]) \*LOF: partial loss of ER and occasional network discontinuities at distal regions; impaired anterograde transport ([@B411])                                                                                                            ALS ([@B90]) Multiple sclerosis ([@B173])
  RyR              ER-Ca^2+^ release                                                                                             KD: decreased axon degeneration ([@B382]); decreased synaptic facilitation ([@B417]; [@B403]); decreased presynaptic Ca^2+^ ([@B323])                                                                                                                                                                                                                                                                                                                                                                                                                                                      AD ([@B77])
  Sec22b           ER-PM tethering Interaction with lipid transfer proteins                                                      LOF: impaired axon growth ([@B266])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        AD ([@B422])
  Sec61β           ER-MTs interaction                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       PD ([@B385])
  Seipin           ER-LDs tethering LDs growth regulation                                                                        KD: impaired regeneration ([@B282])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        **CMT** ([@B15]) **HSP** ([@B400]) PD ([@B203]) **Silver syndrome** ([@B400]) **Spinal CMT** ([@B400]) **Progressive encephalopathy** ([@B129])
  SERCA            ER-Ca^2+^ uptake                                                                                              KD: decreased presynaptic Ca^2+^ and exocytosis ([@B73]); decreased amplitude of excitatory postsynaptic potentials ([@B82])                                                                                                                                                                                                                                                                                                                                                                                                                                                               AD ([@B181]) Diabetes-induced neuropathy ([@B380]) PD ([@B194])
  SigR1            Regulation of ER-Ca^2+^ release channels                                                                      KD: decreased axonal length ([@B366]) LOF: impaired anterograde transport ([@B366])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        AD ([@B229]; [@B141]) **ALS** ([@B8]; [@B275]) Chemotherapy-induced peripheral neuropathy ([@B44]) HD ([@B160]; [@B226]; [@B292]) PD ([@B228]; [@B234]) **Spinal CMT** ([@B201])
  spastin          ER-Endosomes tethering MT severing LDs growth regulation                                                      KD: impaired axon outgrowth ([@B401]); reduced presynaptic area, increased excitatory junction potential amplitude, and accumulation of stabilized MTs ([@B365]); loss of LDs ([@B258]); enhanced endosomal tubulation ([@B6]) LOF: reduced axonal length ([@B332]); impaired regeneration ([@B339]); decreased presynaptic terminals size, decreased quantal content, and presynaptic loss of stabile MTs ([@B316]); large lysosomes ([@B5]) OE: reduced excitatory junction potential amplitude and presynaptic loss of stabile MTs ([@B365]); increased LDs size and number ([@B258])   **HSP** ([@B139])
  STIM1            ER-PM tethering Regulation of ER-Ca^2+^ uptake ER-MTs interaction                                             KD: impaired presynaptic Ca^2+^ influx and exocytosis ([@B73]) LOF/OE: impaired axon guidance ([@B321]) LOF: reduced ER translocation into growth cone filopodia ([@B261])                                                                                                                                                                                                                                                                                                                                                                                                                 AD ([@B132])
  STIM2            Regulation of ER-Ca^2+^ uptake                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           AD ([@B37]; [@B343])
  Syntaxin14       LDs growth regulation at ER-LDs contacts                                                                      LOF: reduced myelinated axonal tracts with vacuolization ([@B1])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           **SCA** ([@B362]; [@B326])
  TBC1D20          LDs growth                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               **WARBM** ([@B204])
  VAPB             Tubular ER morphogenesis Tubular ER dynamics ER MCSs tethering via interaction with lipid transfer proteins   KD: decreased synaptic activity ([@B121]) \*KD: ER discontinuity, impaired ER tubules dynamics, and decreased presynaptic Ca^2+^ influx and synaptic vesicle cycling ([@B207]) \*LOF: impaired axonal localization of Dscam cell surface receptors ([@B413]); decreased number and increased size of presynaptic terminals, and impaired presynaptic MT network ([@B263]); decreased presynaptic BMP signaling ([@B283]) \*OE: increased number and decreased size of presynaptic terminals ([@B263]); decreased presynaptic active zones ([@B283])                                        **ALS** ([@B245]) **SMA** ([@B245])
  VPS13A           ER-Mitochondria tethering ER-LDs tethering                                                                    KD: neurite degeneration ([@B259])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         **Chorea-acanthocytosis** ([@B369]; [@B315])
  VPS13C           ER-Endosome/Lysosome tethering ER-LDs tethering                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          **PD** ([@B199]; [@B306])
  **^\#^**VPS13D   Regulation of mitochondrial size and clearance                                                                KD: decreased mitochondrial content in distal axons ([@B313])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              **HSP/ataxia** ([@B114]; [@B313])

In the "
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and the main text; in the "

Reported phenotypes in axons

" column, \* refers to evidences reported by affecting not only the corresponding specific protein, but several or all the members of the protein family.

KD

,

Knock-down; LOF

,

loss of function; OE

,

overexpression;

in the "

Neurological disorders associated

" column, bold type indicates neurological disorders where mutations or variants in the corresponding gene were found in patients; for other disorders, there is evidence relating the protein with the pathogenic mechanisms, but not necessarily as a primary cause of the disease.

AD

,

Alzheimer's disease; ALS

,

amyotrophic lateral sclerosis; CMT

,

Charcot-Marie-Tooth disease; HSN

,

hereditary sensory neuropathy; HSP

,

hereditary spastic paraplegia; HD

,

Huntington's disease; PD

,

Parkinson's disease; SCA

,

spinocerebellar ataxia; SMA

,

spinal muscular atrophy; WARBM

,

Warburg micro syndrome.

Axonal ER Organization {#S3.SS1}
----------------------

Local ER organization is mediated by a group of evolutionary conserved protein families found in the ER membrane, each one specialized in regulating particular aspects of ER morphology. Axonal ER is mostly composed of tubular ER ([Figure 1](#F1){ref-type="fig"}). Therefore, to understand axonal ER biology, it is critical to know how the tubular ER network is regulated. It is well established that reticulons (RTNs) and REEP proteins drive formation of ER tubules ([@B383]; [@B19]). In yeast, these two protein families are together essential for most peripheral ER tubules ([@B155]), although in other organisms like *Drosophila*, the absence of RTNs and REEPs is not enough to abolish ER tubule formation in axons ([@B411]), indicating that additional proteins are involved in formation of ER tubules in neurons. RTNs and REEPs are proposed to control ER tubulation through their hydrophobic intramembrane domains, which insert in the cytosolic face of the ER lipid bilayer, distorting it and inducing local curvature of the bilayer ([@B319]) ([Figure 1](#F1){ref-type="fig"}). Also, Pex30, a yeast protein enriched at sites of nascent LDs and peroxisomes on ER, is found in tubules and the edges of sheets, as are RTNs. Pex30 has a reticulon homology domain (RHD), as does its closest human homolog, MCTP2. Expression of Pex30 ([@B167]) or MCTP2 RHD restores ER tubules in yeast lacking RTNs ([@B168]). Therefore, in addition to their role in lipid metabolism, Pex30/MCTP2 may have a redundant role with RTNs and REEPs in tubular ER formation.

Other proteins that can shape tubular ER include ADP-ribosylation factor-like 6 interacting protein 1 (ARL6IP1) ([@B412]) and protrudin ([@B52]). Both are found in tubular ER and possess hairpin-loop domains like RTNs and REEPs. However, the presence of a short polar stretch in the middle of their potential hairpins suggest that they span the entire ER membrane. Nevertheless, there is evidence for roles for both ARL6IP1 and protrudin in shaping tubular ER. In *Drosophila* larval motor neurons, ARL6IP1 knockdown disrupts ER distribution at axon terminals ([@B107]). In addition, ARL6IP1 recruits INPP5K, an inositol 5-phosphatase enriched in newly formed ER tubules. Loss of ARL6IP1 or INPP5K leads to an increase in ER sheets ([@B87]), consistent with the idea that ARL6IP1 promotes formation of ER tubules. Also, protrudin depletion in mammalian cells alters ER network morphology, promoting the extension of ER sheets ([@B52]), again consistent with a role in promoting formation of ER tubules.

Axonal ER forms a network of interconnected tubular structures. Fusion between ER tubules is mediated by the atlastins (ATLs), a family of GTPases that mediate fusion between ER membranes in a GTP-dependent manner ([@B252]). As in yeast and mammalian cell culture models ([@B156]; [@B180]; [@B387]), depletion of ATL in *Drosophila* neurons leads to tubular ER fragmentation and unbranched ER tubules ([@B252]). Similar branching defects have also been reported in *C. elegans* neurons mutated in *atln-1*, the *ATL1 ortholog* ([@B209]). In addition to their GTPase catalytic domain, ATLs also possess intramembrane domains, similar to those found in RTNs and REEPs, that are not only essential for ATL membrane fusion activity, but also could explain why ATL1 drives the generation of membrane tubules from proteoliposomes *in vitro* ([@B30]).

Another protein with an ER intramembrane domain is the M1 form of the MT-severing protein spastin ([@B260]), which interacts with RTNs ([@B219]), REEPs and ATLs ([@B260]). However, there is not yet any evidence for a direct role for spastin in promoting formation of ER tubules. Similarly, a potential role of FAM134B protein in ER tubulation is not clear. FAM134B contains a predicted RHD, and its loss produces expanded ER sheets. Also, via its RHD, FAM134B binds to liposomes and produces highly curved proteoliposomes. However, FAM134B is mainly found in perinuclear ER, where it has been proposed to promote curvature at the edges of sheets ([@B174]; [@B31]).

ER-shaping proteins that mediate tubulation, such as RTNs and REEPs, localize not only in tubular ER, but also at the edges of ER sheets ([@B320]), both regions with high curvature. Another ER-resident protein whose localization is related to its function is Lunapark. This protein is directly involved in shaping the ER tubular network by stabilizing three-way junctions between ER tubules, where it also localizes ([@B57], [@B56]). Absence of Lunapark in mammalian cells increases the amount of ER sheets, but does not abolish the formation of an ER tubular network ([@B387]; [@B423]), suggesting that although required to stabilize the three-way junctions, Lunapark is not essential to develop ER tubules.

Roles in shaping tubular ER are not confined to proteins with intramembrane hairpin domains. For example, the small GTPases Rab10 and Rab18 regulate tubular ER morphology: depletion of Rab10 produces expansion of cisternal ER and fewer ER tubules ([@B97]), and loss of Rab18 from ER tubules, by depletion of the Rab3GAP complex (which is also a Rab18 GEF), causes fragmentation of the ER tubular network and spread of ER sheets ([@B118]). Another example is the RNA-binding protein Ataxin-2, also associated with ER, whose depletion causes formation of ER aggregates in the peripheral ER network of *Drosophila* neurons ([@B76]). Mitofusin-2 (MFN2) is found at both mitochondria and ER membranes, being particularly enriched at the latter. A role for ER MFN2 in ER tubulation has been proposed, since it is required to keep luminal continuity at the peripheral ER in mammalian cells ([@B71]). VAPA/B are also found at ER membrane and required for axonal ER continuity ([@B207]).

Finally, one characteristic feature of axonal ER is its very small diameter -- ER tubules in most cells frequently has a diameter of ∼60 nm (varying between 25 and 90 nm), but in axons, ER tubules have a diameter on average around 40 nm, and often becoming small enough for the lumen not to be even visible ([@B407]; [@B411]; [@B353]). The reasons for this specialization are unclear, but the predicted consequences include limited capacity to either release or sequester Ca^2+^, as well as limitations on both Ca^2+^ tunneling and glucose tunneling. Therefore, while ER continuity appears to be important for its function, there also appear to be reasons to constrain lumen continuity.

Axonal ER Membrane Contact Sites (MCSs) {#S3.SS2}
---------------------------------------

The continuity of the axonal ER network suggests a role for it in communicating throughout neurons, but also provides capacity to regulate cellular processes at local or regional levels. Tubular ER has MCSs with nearly every membranous organelle, including PM ([@B94]; [@B269]; [@B404]) ([Figure 2](#F2){ref-type="fig"}). This is also true for axonal ER, where focused ion-beam scanning electron microscopy (FIB-SEM) reveals membrane domains in close proximity to other organelles ([@B407]). Although most of our understanding of ER MCSs comes from yeast and mammalian non-neuronal cells ([@B93]), the molecular machinery associated with these MCSs is present in axons ([@B25]). ER MCSs are not mere physical attachments between ER and other organelles; depending on both the organelle and their function, they can be enriched for different proteins. For example, some MCSs are related to Ca^2+^ exchange, others for lipid exchange ([@B93]). Impairment of these MCSs disrupts organellar communication and can cause diverse cellular defects, including in organelle dynamics ([@B110]; [@B217]; [@B291]), lipid metabolism ([@B32]; [@B158]) or Ca^2+^ levels ([@B27]; [@B73]). Here, we summarize the different MCS known between ER and other organelles, and those MCSs reported in neurons.

### ER-Mitochondria MCS {#S3.SS2.SSS1}

In mouse neurons, axonal ER tubules typically contact around 5% of mitochondrial surface ([@B407]). Although it is still unknown which signals control the formation and maintenance of these MCSs, we know about some molecules located there. ER-shaping protein REEP1 is reported not only at ER membrane, but also at mitochondrial membrane, and to be required for ER-mitochondria interactions in non-neuronal cells ([@B205]). A role for MFNs in ER-mitochondria tethering has been also reported in non-neuronal cells ([@B71]), and they are proposed to have a similar role in neurons, where they are required for proper mitochondrial dynamics ([@B428]). Another tethering complex in neuronal cells comprises VAPB (at ER membrane) bound to the mitochondrial protein tyrosine phosphatase-interacting protein 51 (PTPIP51) ([@B74]; [@B338]). The VAPB-PTPIP51 tether has been specifically reported in presynaptic regions; neuronal activity increases presynaptic VAPB-PTPIP51 MCSs; and loss of either VAPB or PTPIP51 reduces synaptic activity, suggesting an important role for VAPB-PTPIP51 MCSs in synaptic function ([@B121]). Also in neurons, the ER membrane protein PDZD8 promotes ER-mitochondria MCSs ([@B146]).

ER-mitochondria MCSs are required for diverse processes, including controlling mitochondrial Ca^2+^ levels. ER is a major Ca^2+^ source, and mitochondria can take up Ca^2+^ from ER via ER-mitochondria MCSs, where Ca^2+^ exits the ER lumen through the IP3R, which is required for maintaining ER-mitochondria MCSs ([@B16]). IP3R is stabilized by the ER chaperone Sigma receptor-1 (SigR1) ([@B138]), and binds to the voltage-dependent anion channel (VDAC) on mitochondrial outer membrane ([@B47]). IP3R-VDAC interaction is stabilized by the molecular chaperone glucose-regulated protein 75 (grp75) ([@B345]). After exiting the ER lumen, Ca^2+^ is translocated into mitochondria by calcium uniporters. Mitochondrial Ca^2+^ levels control ATP production by activation of key metabolic enzymes in the Krebs cycle ([@B115]), and at high levels, promote apoptosis by opening the mitochondrial permeability transition pore (mPTP) and allowing release of mitochondrial contents to the cytosol ([@B18]). Therefore, ER-mitochondria MCSs have a critical role in mitochondrial function by controlling mitochondrial Ca^2+^ levels. Enrichment and function of VDAC, IP3R, SigR1 or grp75 proteins at ER-mitochondria MCSs has been specifically reported in neurons ([@B325]; [@B145]; [@B223]), including in axons ([@B27]).

Some of the enzymes required for the biosynthesis of mitochondrial lipids, such as phospholipids or cholesterol, are found in the ER membrane, and interestingly, enriched at ER-mitochondria MCSs, where lipids are exchanged between both organelles ([@B375]). Mitochondrial function ([@B352]) and balanced fusion and fission ([@B335]) are dependent on specific lipid composition, and therefore, lipid exchange at ER-mitochondria MCSs may be critical in regulating these processes. The Vps13 family of lipid-transfer proteins are localized to a variety of intracellular membrane contacts; of these, Vps13A (vacuolar protein sorting-associated protein 13A), which directly interacts with VAPA ([@B414]), is found at mammalian ER-mitochondrial MCSs ([@B187]), although it is not known how much it contributes to lipid transport there ([@B267]). Oxysterol binding protein (Osbp)-related proteins ORP5 and ORP8 are also found at ER-mitochondria MCS, where they mediate non-vesicular transport of phosphatidylserine from the ER to mitochondria in mammalian cells ([@B287]).

Mitochondrial fusion and fission events are driven by membrane-bound GTPases like MFNs and dynamin related protein (DRP-1) ([@B152]). In addition to the above-mentioned role for MFNs in tethering ER-mitochondria MCSs, DRP-1 recruitment to mitochondria occurs after ER tubules mark the mitochondrial constriction site ([@B110]), suggesting a critical role for ER-mitochondria MCSs in mitochondrial dynamics. Moreover, a role for tubular ER in this process is supported by the fact that knockdown of key ER-shaping proteins such as ATL3, RTN1, RTN4, or Lunapark produces structural alteration of mitochondria in human cells ([@B227]; [@B182]). These evidence comes from non-neuronal cells, but since ER-shaping proteins control tubular ER in axons (see above), it is reasonable to expect that axonal ER regulates mitochondrial dynamics similarly. Another role attributed to ER-mitochondria MCSs and pending exploration in neurons, is the formation of autophagosomes ([@B133]), which mediate the fundamental cellular process of autophagy ([@B232]).

### ER-PM MCS {#S3.SS2.SSS2}

Contacts between large flat ER cisternae and PM are mostly seen in neuronal cell bodies, but also in axons, where between 0.5 and 1% of the PM surface contacts ER ([@B407]). Depending on function, these MCSs can be mediated by various ER membrane proteins, allowing exchange of particular lipids or Ca^2+^ between ER and PM membranes ([@B293]).

Ca^2+^ exchange at ER-PM MCSs can be mediated by different molecular complexes. In non-neuronal cells, the ER Ca^2+^ sensor STIM1 binds a store-operated channel (SOC), the PM Ca^2+^ channel Orai1, in a process stimulated by Ca^2+^ depletion in ER to induce Ca^2+^ influx from the extracellular medium ([@B49]). In contrast to its stabilizing role on the ER-Ca^2+^ release channel IP3R (see above), SigR1 associates with STIM1 and attenuates its interaction with Orai1 ([@B334]). In neurons, the role described for STIM1 seems to be mostly performed by its paralog STIM2 ([@B24]), whereas STIM1 activation in presynaptic terminals locally modulates presynaptic function, impacting activity-driven Ca^2+^ entry and release probability ([@B73]).

PM voltage-gated K^+^ channels (Kv) and ER RyR Ca^2+^ channels also accumulate at ER-PM MCSs in neurons ([@B217]), controlling local Ca^2+^ homeostasis and the formation of these MCSs ([@B108]; [@B178]). Other molecules related to ER-PM MCSs are junctophilins (JPHs), ER membrane proteins that bind the PM through their N-terminal domain. In addition to tethering both membranes, JPHs have a role in PM-ER Ca^2+^ signaling, potentially by their interaction with Ca^2+^ channels and/or facilitating the interaction between Ca^2+^ channels from both membranes ([@B189]). Although this role has been mainly studied in muscle junctional membrane complexes, which are formed between the sarcoplasmic reticulum and T-tubule membranes, there is evidence supporting a similar role for JPHs in neurons ([@B235]; [@B294]).

ER-PM MCSs also allow transport of lipids. Similar to mitochondria, enzymes for the biosynthesis of some PM lipids are found in ER membranes. This compartmentalization of lipid metabolic enzymes facilitates regulation of the lipid composition of both membranes ([@B192]), which affects key cellular processes such as the actin cytoskeleton, membrane protein recruitment, and vesicle trafficking ([@B364]). Extended synaptotagmins (E-Syts), integral ER membrane proteins, bind to PM phosphatidyl inositol 4,5 bisphosphate (PI(4,5)P~2~) and transfer glycerophospholipids between ER and PM in a Ca^2+^-dependent manner ([@B415]; [@B32]) harboring lipids within their SMP (synaptotagmins-like-mitochondrial-lipid binding protein) domain ([@B302]; [@B165]). In *Drosophila* neurons, *E*-Syt localizes at axonal ER, and is required for proper neurotransmission and synaptic growth. However, at least in the presynaptic region, E-Syt may not be required for lipid homeostasis, since synaptic balance of phospholipids PI(4,5)P~2~ and PI(3)P appears normal in E-Syt mutants ([@B175]). Transmembrane protein 24 (TMEM24), also regulated by Ca^2+^ and with SMP domains, is enriched at ER-PM MCSs, where it acts as a tether and transfers phospholipids in mammalian neurons, including in axons ([@B342]).

As at MCSs between ER and other organelles, VAP proteins mediate tethering between ER and PM membranes, indicating a general role for these proteins in the formation of ER MCS. VAPs can recruit diverse proteins with lipid-binding domains to the ER by binding to FFAT \[diphenylalanine (FF) in an acidic tract\] motifs in these proteins, allowing exchange of phospholipids, ceramides or sterols between both membranes ([@B240]). Moreover, the SNARE proteins Sec22b (ER-resident) and Syntaxin1 (PM protein) mediate non-fusogenic MCSs between ER and PM in neurons. This tether contributes to PM expansion in growth cones ([@B266]), a process thought to be controlled by non-vesicular lipid transfer ([@B131]). Since Sec22 interacts with lipid transfer proteins Osh2 and Osh3 (oxysterol-binding homology proteins 2 and 3; phosphoinositide-binding proteins) in yeast, it is proposed that Sec22b-Syntaxin1 interaction may regulate neuronal PM growth by controlling lipid synthesis and transfer ([@B266]).

### ER MCS and Intracellular Membrane Trafficking {#S3.SS2.SSS3}

Endocytosed molecules from the PM are delivered to endosomes, where they are sorted for traffic to other compartments, for example to lysosomes for degradation ([@B96]). ER and endosomes form dynamic MCSs, where both organelles are linked to MTs ([@B109]). ER-endosome MCSs are reported in axons, where ER contacts tubulovesicular structures (early endosomes), multivesicular bodies (late endosomes) and lysosomes ([@B407]). MCSs between ER and endosomes can be mediated by VAP and lipid-binding proteins, allowing exchange of lipids like cholesterol or phospholipids ([@B91]). One lipid-transfer protein associated with these MCSs is Vps13C ([@B187]). In addition, endosomal cargoes can interact with ER membrane proteins, as revealed by the interaction between the ER-localized protein tyrosine phosphatase PTP1B and the endosome-associated epidermal growth factor receptor (EGFR). In this interaction, PTP1B dephosphorylates EGFR and leads its degradation ([@B92]). Similar than its role on mitochondrial dynamics, ER contacts define the position of endosome fission ([@B291]; [@B154]). No evidence of lipid transfer between ER and endosomes have been reported in axons yet. However, a role for tubular ER (including in neurons) in regulating endosomal dynamics has been proposed. The ER-shaping protein and MT-severing ATPase spastin, is required to initiate endosomal tubule fission at ER-endosomal MCSs. Failure in this process causes increased endosomal tubulation ([@B6]) and abnormal lysosomal morphology ([@B5]).

Both LDs and peroxisomes, with roles in lipid storage and lipid degradation respectively, can be generated from ER ([@B168]). Moreover, the distribution and function of these two organelles depend on their contacts with ER ([@B249]; [@B103]). ER-peroxisome contacts can be mediated by VAP proteins and the endosomal-associated protein acyl-coenzyme A--binding domain protein 5 (ACBD5) ([@B67]; [@B158]). In neurons, overexpression of ACBD5 produces diminished peroxisomal long-range movements, along with accumulation of peroxisomes in dendrites and axons ([@B389]).

During LD biogenesis, membrane continuity is observed between LD and ER, forming membrane bridges. In addition, LDs also associate with the ER, at sites where protein complexes tether the membranes of both organelles. Molecules identified at these tethers include a complex formed by diacylglycerol *O*-acyltransferase 2 (DGAT2) (in LD membrane) and the fatty acid transport protein FATP1 (in ER membrane) ([@B409]); one formed by LD-associated Rab18 with the ER-associated proteins NAG-RINT1-ZW10 (NRZ complex) and Syntaxin18, Use1 and BNIP1 (SNARE proteins) ([@B408]); and tethering mediated by Vps13A and Vps13C ([@B187]). At least one of them, Vps13A, interacts with the ER-membrane protein VAP-A ([@B414]). These tethers, which are involved in LD biogenesis, have not been reported in neurons yet. Nevertheless, ER membrane proteins REEP1 ([@B101]) and spastin ([@B258]) are associated with LDs in neurons, controlling LD distribution and size. A similar role has been reported in non-neuronal cells for additional ER membrane proteins, such as ATL ([@B179]), seipin ([@B386]; [@B297]), LD-associated hydrolase (LDAH) ([@B123]) or Syntaxin14 ([@B70]). Interestingly, ATL ([@B425]), seipin ([@B163]) and LD-associated hydrolase (LDAH) *Drosophila* ortholog ([@B360]; [@B411]), localize at neuronal ER tubules. Therefore, they may perform a similar role in LD biogenesis in neurons.

In cell bodies and in non-neuronal cells, ER exchanges material with the Golgi apparatus via both vesicle trafficking, and non-vesicular transport mediated by MCSs ([@B301]). These contacts between ER and Golgi also depend on VAP and lipid-binding proteins, allowing exchange of lipids such as ceramides or phospholipids. Although canonical Golgi structures have not been observed outside the cell body, Golgi-derived structures, called Golgi outposts, are found in dendrites ([@B112]; [@B270]; [@B153]). Golgi outposts have been also reported in axons during synapse development ([@B344]) and in mature axons ([@B122]), mediating vesicular trafficking with ER, and revealing a machinery for the local processing of membrane proteins. Whether axonal ER and Golgi outposts also possess MCS remains unknown.

Axonal ER Dynamics {#S3.SS3}
------------------

During cell development, ER material is organized and distributed through the cell ([@B35]). For example, in axon growth cones, dynamic ER tubules drive ER network extension into the cell periphery ([@B69]; [@B102]). During these stages, ER tubule distribution is not "sculpted" to remain unalterable, but remains highly dynamic even in differentiated cells and neurons. New tubules grow from old ones, old tubules retract, new junctions appear, and cisternae relocate. Remarkably, this dynamic nature is evolutionary conserved, being observed in plants ([@B337]), yeast ([@B89]) and animal cells ([@B193]; [@B246]; [@B308]), indicating that the capacity of tubular ER to change its distribution plays a critical role in cell responses to physiological changes \[i.e., ER stress ([@B309]) or Ca^2+^ levels ([@B284]; [@B43]), or to control processes such as cell motility ([@B142]) or cell division ([@B35]; [@B211])\]. The continuity of the ER network within the confined dimensions of axons obscures some features of ER dynamics, but anterograde and retrograde transport of ER tubules can be seen superimposed on the apparent stability of the continuous network ([@B411]). Since the axonal ER network is dynamic, since the ER assembly mechanisms appear to be quite efficient at maintaining a continuous network and avoiding gaps even when ER tubule numbers are significantly reduced, and since there appear to be no physical constraints on an even denser network of ER tubules ([@B411]), we suggest the existence of homeostatic mechanisms to achieve the physiological density and continuity of ER tubules. These mechanisms would ensure the presence of enough ER tubules to maintain continuity by fusing and joining up gaps in the network, while avoiding the presence of excess ER tubules; such mechanisms would depend on a pool of free mobile tubules through which excess tubules can be transported away, or required tubules delivered.

### MT-Mediated Tubular ER Dynamics {#S3.SS3.SSS1}

Although some components of the ER-shaping machinery are sufficient to generate tubules *in vitro* (i.e., RTNs), MTs are additionally required *in vivo* ([@B354]; [@B69]; [@B211]; [@B102]). In animal cells, peripheral ER tends to co-align with MTs ([@B354]; [@B177]; [@B102]), which drive the movement of ER tubules. Two different mechanisms have been described for how ER tubules move alongside MTs ([Figure 3](#F3){ref-type="fig"}). One of these involves movement of individual ER tubules on extending MTs, mediated by the tip attachment complex (TAC). In TACs, the tip of an ER tubule is attached to the tip of a MT plus end, through a complex containing the ER protein STIM1 and the MT-associated protein EB1. This binding leads to the ER tubule movement when the MT grows or retracts ([@B125]; [@B261]). The other mechanism mediating ER tubule movement along MTs, faster and more frequent than TAC, is ER sliding, driven by MT motor proteins such as kinesin-1 and dynein ([@B402]). In ER sliding, the tip of an ER tubule binds to stable (acetylated) MTs, and ER movements result from ER transport along the MT. Since this movement is MT-motor dependent, it does not necessarily correlate with MT growth or shrinkage ([@B193]; [@B393]; [@B402]). TAC-mediated movement and ER sliding are independent of each other, for example, ER sliding is still observed when STIM1 or EB1 are mutated ([@B125]), or in the presence of nocodazole, which depolymerizes non-acetylated MTs ([@B354]; [@B393]).

![Microtubule (MT)-mediated transport of ER tubules. (1) Tip attachment complex (TAC) is formed between a MT plus end and the tip of an ER tubule through STIM1-EB1 interaction, resulting in movement of the ER tubule when the MT grows or retracts. (2) In ER sliding mechanism, the tip of an ER tubule associates to MTs, where motor proteins kinesin and dynein mediates, respectively, anterograde and retrograde movement of the ER tubule.](fnins-14-00048-g003){#F3}

STIM2 and EB3, paralogs of STIM1 and EB1 respectively, are preferentially expressed in the central nervous system ([@B241]; [@B330]), and they also physically bind each other ([@B125]), what suggests that STIM2-EB3 complex may mediates TAC in neurons. However, although knockdown of both EB1 and EB3 reduces dendritic ER expansion, it does not affect axonal ER distribution ([@B102]), suggesting that TAC mechanism may not be essential for axonal ER transport. Conversely, knockdown of kinesin-1 or dynein disrupts anterograde or retrograde transport, respectively, of ER tubule along the axon ([@B102]), supporting a critical role for ER sliding in axonal ER transport. In spite of this, it is still not clear which ER molecules serve as adaptors. One component of the complex that binds ER and MTs may be Protein 600 (p600), which appears associated with MTs and ER tubules in neurons ([@B322]). In addition, several integral ER membrane proteins are able to bind MTs. One of them is kinectin, proposed as an ER adaptor for kinesin-1 ([@B185]), mediating ER extension ([@B418]). However, kinectin associates with ER sheets, and is excluded from axons ([@B102]). P180 protein, which contains a kinectin-homologous region and two MT-binding domains, also can bind kinesin-1 ([@B83]), and interestingly, its distribution is not only restricted to the ER cisternae in the soma. P180 is also found at axonal ER tubules, from where it stabilizes MTs ([@B102]). Similarly, Sec61β, a subunit of the Sec61 translocon complex, is present in both soma and axon ([@B102]), and interacts directly with MTs ([@B427]). Also, REEP1 and spastin can bind MTs, promoting respectively ER alignment along MTs ([@B260]) and MT severing ([@B288]). Nevertheless, the potential role for these ER proteins in ER transport remains to be explored.

Axonal ER is mostly composed of interconnected ER tubules, with occasional small sheets or cisternae ([@B407]; [@B411]). Antagonistically to tubular ER-shaping proteins, ER membrane protein Climp63 promotes formation of ER sheets, stabilizing them through homodimeric luminal bridges ([@B320]). Interestingly, Climp63 mediates static interactions with MTs, stabilizing the ER network ([@B379]).

### ER-Shaping Proteins and Tubular ER Motility {#S3.SS3.SSS2}

Proteins that shape or regulate tubular ER also influence ER tubule motility, although the mechanisms for this are not always clear. For example, Rab10 depletion decreases both extension frequency and fusion efficiency of ER tubules ([@B97]). Rab10 is enriched at the leading edge of nearly half of all dynamic ER tubules, and these dynamic domains track along MTs ([@B97]), suggesting a direct role for Rab10 in regulating tubular ER movements along MTs. VAPA/B knockdown impairs tubular ER movements in axons ([@B207]), potentially by affecting ER MCSs, which may destabilize the ER network. Also, RTN overexpression reduces retraction speed and increases fission frequency of ER tubules ([@B98]); since RTN is distributed along the tubular ER network, its role in ER dynamics might simply result from its effect on the physical properties of the ER tubules.

### ER MCS Dynamics {#S3.SS3.SSS3}

ER movements also result from transport of ER-associated organelles along MTs. As they traffic, endosomes and mitochondria can keep their MCS with ER, which results in changes in the position and morphology of the tethered ER tubules ([@B404]). This may be a way to ensure that during traffic events, ER tubules still can regulate these organelles, including their fission, lipid composition, or Ca^2+^ levels. The number and the size of ER MCS are highly dynamic, and dependent on physiological conditions. For example, Ca^2+^ levels can regulate ER-PM lipid exchange through the control of E-Syt tethering and function ([@B415]; [@B32]), and also STIM1 activation, promoting STIM1-Orai1 tethering to mediate Ca^2+^ exchange between ER and PM ([@B49]). Key cellular functions have also been associated with ER-mitochondria MCS dynamics. For example, mitochondrial ATP production depends on mitochondrial Ca^2+^ uptake at ER-mitochondria MCSs. The importance of balanced ER-mitochondrial MCSs is illustrated by the fact that excessive mitochondrial Ca^2+^ uptake from ER can turn detrimental for the cell, triggering excessive opening of the mPTP and causing apoptosis ([@B255]).

### ER Turnover {#S3.SS3.SSS4}

To maintain ER homeostasis, the ER network requires a regulated system to remove excessive ER expansion. In addition, removing ER could facilitate network remodeling. Most of our knowledge about ER autophagy (ER-phagy) is related with the unfolded protein response (UPR), a degradative system that allows the removal of excessive accumulated misfolded and unfolded proteins in the ER lumen ([@B206]), and therefore, mostly associated with rough ER. An additional role for ER-phagy is turnover and clearance of ER ([@B126]). This process is regulated by integral ER proteins, which act as ER-phagy receptors, targeting ER fragments to autophagosomes for lysosomal degradation. To date, six different ER-phagy receptors (see below) have been identified. Each of them specifically binds to ATG8 family members, such as LC3 and GABARAP, which are found in the membrane of incipient autophagosomes ([@B33]). Consistent with the hypothesis that ER-phagy can be activated locally to regulate ER excess, different ER-phagy receptors are found at different ER network domains. For rough ER, an ER-phagy receptor role has been reported for Sec62, a member of the translocon complex ([@B111]), and for cell-cycle progression gene 1 (CCPG1), which is activated by the UPR ([@B331]). Similarly, ER-phagy receptor FAM134B has been linked to turnover of perinuclear ER cisterna ([@B174]; [@B31]). Remarkably, the molecules identified as tubular ER-phagy receptors are tubular ER-shaping proteins. A long RTN3 isoform, which contains several LC3-interacting regions in its large amino-terminal domain, can promote degradation of ER tubules ([@B127]). A similar role for ATL3 has also been observed ([@B55]). Recently, the predicted single-pass transmembrane ER protein, TEX264, was identified as an ER-phagy receptor ([@B10]; [@B62]), specifically mediating the degradation of ER tubule three-way junctions ([@B10]). All these ER-phagy receptors have been studied in non-neuronal mammalian cells, and their roles in neurons remain to be explored. More comprehensive details about ER-phagy process can be found in recent specific reviews ([@B126]; [@B398]).

ER and Axonal Neurodegeneration {#S4}
===============================

The physiological roles of ER discussed above make it an obvious potential site of degenerative pathology, for example from impaired lipid, Ca^2+^, or organelle homeostasis. However, its physical properties, in particular its continuity, offer additional vulnerabilities for pathology. A summary of the evidence relating tubular ER and neurological disorders is presented in [Table 2](#T2){ref-type="table"}. In this section, we will cover the relationship between axonal ER and some neurodegenerative diseases, by looking at causative mutant proteins and their potential roles in disease mechanisms (summarized in [Figure 4](#F4){ref-type="fig"}).

![Potential routes underlying axonal ER involvement in neurodegeneration. Bold type shows pathways by which axonal ER may influence other cellular compartments/organelles, where the specific processes regulated in each case are indicated. Blue-border text boxes show processes indirectly regulated by ER. Arrows show regulation of the indicated process. Broken lines show consequences of disrupting the corresponding process.](fnins-14-00048-g004){#F4}

Hereditary Spastic Paraplegias (HSPs) {#S4.SS1}
-------------------------------------

The HSPs are a group of inherited, progressive, heterogeneous diseases, predominantly characterized by degeneration of longer upper motor neurons (those with somata in the brain, and axons projecting down the spinal cord). In "pure" HSPs, the main symptoms are lower limb weakness and spasticity. Additional symptoms are observed in "complicated" HSPs, including cerebellar ataxia, peripheral neuropathy, or optic atrophy, among other symptoms. Over 80 distinct spastic gait genetic loci (SPG1-80 and others) are so far known to be causative for HSP. These genes implicate cellular pathways such as membrane shaping and trafficking, mitochondrial function, lipid and protein metabolism, and axon development ([@B34]; [@B39]). Remarkably, around half of HSP patients carry mutations affecting the ER-shaping proteins spastin, ATL1, RTN2 or REEP1 ([@B39]), suggesting a relationship between ER modeling and axon maintenance. Other SPG proteins, e.g., REEP2 ([@B99]), ARL6IP1, Rab3GAP2 ([@B247]), or seipin ([@B400]) affect ER morphogenesis, and others are also localized on ER ([@B202]), supporting the idea that ER maintenance is essential for axonal maintenance. Mutations in Vps13D, required for mitochondrial size and clearance ([@B11]), are also causative for recessive spastic paraplegia or ataxia ([@B114]; [@B313]), thus suggesting that lipid transfer to or from the ER might be vulnerable in HSP, although the exact subcellular compartments where Vps13D acts are still unknown. There is experimental evidence for roles of several ER-localized SPG proteins in neurite or axon outgrowth ([@B54]; [@B124]; [@B119]). However, at least in the pure HSPs, axon growth and development must be largely unaffected, and the mechanisms that lead to degeneration are not necessarily the same ones that impair neurite outgrowth. In addition to their roles in tubular ER morphogenesis, some of the ER-shaping proteins related to HSP also have roles in other cellular processes, such as lipid metabolism, Ca^2+^ signaling or regulation of MTs.

Both ATL1 and seipin regulate LD growth ([@B346]; [@B179]; [@B386]; [@B297]). In spite of the little information about LD in axons, they are implicated in membrane biogenesis and cellular signaling. Therefore, their role in axons may be relevant in pathogenesis ([@B264]).

REEP1 coprecipitates and co-aligns with polymerized MTs, indicating that it might help to modulate coupling of the tubular ER network with MT dynamics ([@B260]). In cortical motor neuron cell bodies, REEP1 knockout shows reduced complexity of the peripheral ER network, producing a reduced number of ER structures with increased length ([@B19]). REEP1 is also found in axonal growth cones ([@B260]), and its knockdown results in neurite outgrowth defects and degeneration ([@B205]). Moreover, REEP1 is detected at ER-mitochondria MCSs, suggesting that mitochondrial disruption might be due to disrupted tubular ER organization, which affects lipid and Ca^2+^ exchange between ER and mitochondria through contacts ([@B205]).

Spastin is a MT-severing protein that also has roles in ER-endosome interactions and LD maturation ([@B258]; [@B5]). In zebrafish, knockdown of spastin causes reduced outgrowth in motor neuron axons and connectivity problems, as well as apoptosis in other neuron types ([@B401]). In an iPSC (induced pluripotent stem cell) model of spastin-linked HSP, axons displayed swellings with accumulation of mitochondria and tau, suggesting axonal transport problems ([@B81]). Spastin and ATL1 might function in axonal regeneration by mediating amounts of ER and MTs in growing axon tips ([@B200]). All these data suggest that ER dynamics is critical in neurodegeneration and affects not only ER functions but also mitochondria, endosomes, and LDs, perhaps through ER MCSs with them.

*ARL6IP1* knockdown results in abnormal branching of spinal motor neuron axons and a curly tail phenotype in zebrafish, suggesting a role for ARL6IP1 in neuronal development ([@B247]). In *Drosophila*, knockdown of ARL6IP1, which causes tubular ER loss and elongated mitochondria in presynaptic terminals, also leads to a progressive locomotor deficit ([@B107]).

Warburg Micro Syndrome (WRBM) {#S4.SS2}
-----------------------------

WRBM is an autosomal recessive, developmental brain disorder with symptoms including intellectual disability, microcephaly, cataracts in early childhood, and lower limb spasticity ([@B392]). Mutations in *Rab18*, *Rab3GAP1*, *Rab3GAP2*, and *TBC1D20* cause WRBM ([@B23]; [@B38]; [@B135]; [@B204]). RAB3GAP1 and RAB3GAP2 form a heterodimer that (despite the name) is a guanine nucleotide exchange factor that activates Rab18 ([@B118]), and TBC1D20 has been reported as a GTP-activating protein that inactivates Rab18, suggesting a common disease mechanism involving Rab18 signaling ([@B134]). These proteins have roles in ER organization, ER-LD tethering, secretion, and autophagy (including in neurons) ([@B243]; [@B204]; [@B118]; [@B329]; [@B408]; [@B75]; [@B244]). Recruitment of Rab18 to ER by Rab3GAP is essential for a normal ER tubular network, and this is disrupted by disease-causing mutations ([@B118]), making ER a potential site for WRBM pathology. WRBM presents as a complicated spastic paraplegia that progressively spreads to the upper body. Therefore, the paraplegia symptoms could potentially be caused by ER defects as in HSP, with additional symptoms due to other roles of Rab18, Rab3GAP and TBC1D20.

Alzheimer's Disease (AD) {#S4.SS3}
------------------------

Alzheimer's disease is the most common neurodegenerative disease, causing a decline in memory, difficulties in speaking, writing, understanding, identifying objects, and disorientation. Its main molecular hallmarks are extracellular beta-amyloid plaques, intracellular tau tangles, dystrophic neurites (DNs) and dysfunctional mitochondria ([@B303]; [@B186]). Mutations in amyloid precursor protein (APP), and in the proteases that generate beta-amyloid from APP, Presenilin-1 (PS1, PSEN1) and Presenilin-2 (PS2, PSEN2) can cause early-onset AD, and apolipoprotein E/E4 (APOE4), a protein implicated in lipid metabolism and inflammation, is a strong genetic risk factor for late-onset AD ([@B373]; [@B186]).

Dysfunctional tubular ER in DNs is a feature of AD pathology ([@B314]). Mutations in *Rab10* are associated with AD ([@B285]). Rab10 binds to both MTs and tubular ER ([@B322]), potentially mediating interaction between them; therefore, proper axonal ER dynamics and transport may be processes that are vulnerable in AD. The tubular ER-shaping proteins RTN3 and RTN4B interact with β-secretase BACE1 (β-amyloid converting enzyme 1) ([@B140]), and negatively modulate BACE1 cleavage of APP during release of amyloid β peptides ([@B318]; [@B12]). RTN3 but not RTN1 is preferentially localized in DNs ([@B317]), and transgenic mice that overexpress RTN3 accumulate DNs and show impaired learning and memory and synaptic plasticity ([@B157]), suggesting that DNs with RTN3 aggregates (RTN3 immunoreactive DNs, or RIDNs) can cause cognitive dysfunction in AD. Additional ER shaping proteins like REEP2 and REEP5 also localize to RIDNs, but not other structural or ER stress-related proteins, suggesting that RIDN formation is due to accumulation of tubular ER in axons ([@B314]). In addition, aging may facilitate RIDN formation; in AD mouse brains, RIDN formation with abnormal ER tubules in axons increases over time ([@B314]).

Alterations in tubular ER network may also affect ER-mitochondria contacts in AD pathology; PS1 and PS2 are highly enriched in ER-mitochondria MCSs ([@B13]). In fact, amyloid β production is particularly high at ER-mitochondria MCSs, causing increased ER-mitochondria tethering and related functions such as lipid and Ca^2+^ exchange ([@B141]; [@B307]). Altered ER Ca^2+^ homeostasis is becoming a central player in AD pathology. Beta-amyloid plaques impair neuronal Ca^2+^ homeostasis ([@B183]). Aβ oligomers are capable of forming Ca^2+^ permeable channels in the PM, and this alters Ca^2+^ homeostasis by elevating Ca^2+^ in the cytosol, resulting in cytotoxicity ([@B78]). Also, wild type PS1/2, independent of secretase activity, can form Ca^2+^-permeable ion channels in ER membrane to leak Ca^2+^ to the cytosol, whereas in PS1/2 mutants the ER is overloaded with Ca^2+^, similar to aging neurons ([@B368]). In this context, several ER proteins involved in Ca^2+^ signaling (IP3R, RyR, SERCA, SigR1, STIM1, and STIM2) appear related with AD pathogenesis ([Table 2](#T2){ref-type="table"}), supporting a critical role for ER Ca^2+^ in AD. Also, both AD patients and mouse AD models show decreased MFN2 protein levels, correlating with disruption of mitochondria dynamics ([@B391]; [@B216]), and increasing ER-mitochondria MCSs ameliorates AD defects in a *Drosophila* model ([@B113]).

Amyotrophic Lateral Sclerosis (ALS) {#S4.SS4}
-----------------------------------

Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with upper and lower motor neuron death, leading to progressive weakness and atrophy of muscles and to paralysis ([@B137]). Most ALS cases are sporadic, but some are familial ([@B22]). Almost half of the familial cases are due to mutations affecting superoxide dismutase (SOD1), TAR DNA-binding protein 43 (TDP-43), fused in sarcoma (FUS) and dipeptide repeat proteins derived from the *C9ORF72* gene. Another ALS gene encodes VAPB ([@B245]; [@B208]), which like VAPA, localizes to ER and mediates tethering between ER and other organelles ([@B240]), and regulates tubular ER morphogenesis and dynamics ([@B207]). Both VAPA and VAPB expression is reduced in ALS patients, SOD1-ALS mice, and in HeLa cells. ALS-causative mutation of VAPB produces accumulation of VAPB in the cytosol and VAPB aggregates that contain ER tubules (still continuous with the ER and linked to mitochondria outer-membrane). Neurons expressing this *VAPB* mutant allele show increased cell death ([@B357]). In addition to its association with ALS, the same VAPB mutation has been found in spinal muscular atrophy (SMA) patients ([@B245]). SMA is caused by degeneration of alpha motor neurons in the spinal cord, producing progressive muscle paralysis and atrophy ([@B363]).

ER MCSs appear to be important in ALS pathology. In motor neurons isolated from ALS patients and in the spinal cord of SOD1-ALS mice, a proapoptotic and mitophagy-associated protein BNIP1 (BCL2 interacting protein 1) was found as an ALS risk gene, and the expression level of BNIP1 was lowered compared to controls ([@B172]). BNIP1 plays a role in ER network organization by mediating ER membrane fusion ([@B242]). Also, mutations in SigR1, a chaperone that regulates ER Ca^2+^ channels ([@B138]; [@B334]), are associated with ALS ([@B8]; [@B275]). Ataxin-2, an RNA-binding protein required for proper tubular ER morphogenesis and dynamics ([@B76]), is associated with ALS ([@B95]). Depletion of ataxin-2 causes disruption of peripheral ER morphology, more tubular instead of cisternal, and abnormal LD structure together with defective mitochondria morphology in *C. elegans* embryos ([@B76]).

Parkinson's Disease (PD) {#S4.SS5}
------------------------

Parkinson's disease is a common neurodegenerative disorder linked to aging, with symptoms like tremor, rigid muscles, bradykinesia and postural abnormalities. It can be caused by both genetic and environmental factors. A common feature in any form of PD is loss of dopaminergic neurons, which have long unmyelinated axons, with accumulation of intraneuronal Lewy body inclusions ([@B274]). Several crucial cellular pathways, such as ER function, protein degradation, Ca^2+^ signaling and intracellular trafficking, have been linked to PD ([@B60]).

Managing Ca^2+^ homeostasis is one of the main roles of tubular ER. Mutation of *PINK1*, a PD causative gene, increases mitochondrial defects such as loss of membrane potential, increased size, and reduced ATP levels, all of which are rescued in PD cell models by inhibition of mitochondria calcium uniporters, which take up Ca^2+^ released from ER ([@B221]). Also, mutations in α-synuclein cause familial dominant forms of PD ([@B224]); mutant α-synuclein can disrupt ER-mitochondria tethering by binding to VAPB ([@B74]; [@B256]). Therefore, ER-mitochondria contacts may potentially affect the severity of PD symptoms, and offer potential strategies for therapy. *LRRK2* (*leucine rich repeat kinase 2*) is another PD causative gene. In astrocytes, mutant LRRK2 localizes to ER membrane where it suppresses activity of the Ca^2+^ ATPase SERCA, causing Ca^2+^ depletion in ER, and overload of Ca^2+^ in mitochondria via induced ER-mitochondria MCSs, eventually resulting in dysfunctional mitochondria ([@B194]). This mechanism could potentially also operate in neurons and axons. Mutations in *Vps13C*, encoding a lipid-transfer protein localized at both ER-endosome and ER-LD MCSs ([@B187]), are associated with PD, and cause mitochondrial dysfunction and PINK1/Parkin-dependent mitophagy ([@B199]; [@B306]).

Loss of MFN2 results in progressive and retrograde degeneration of dopaminergic neurons in the nigrostriatal circuit in mice, increasing mitochondrial fragmentation and decreasing mitochondrial transport ([@B268]). MFN2 plays a role in mitophagy mediated by PINK1-Parkin, and knockout of MFN2 in dopaminergic neurons leads to impaired localization of Parkin and axonal loss ([@B349]; [@B198]; [@B58]). These data also suggest potential roles of ER and ER tethering in PD mechanisms, as mitophagy occurs via ER-mitochondria physical contacts ([@B36]; [@B277]). Moreover, in *Drosophila* and iPSC PD models, increases in ER-Mitochondria MCSs cause abnormal lipid trafficking, depleting phosphatidylserine from ER. This ER lipid defect impairs sleep patterns ([@B371]), one of the non-motor symptoms associated with PD ([@B239]).

MCTP2 gene, a human homolog of Pex30, with potential roles in tubular ER formation ([@B168]), was found as a risk factor for early onset PD development ([@B191]), suggesting that disrupted ER organization in dopaminergic axons might facilitate PD development.

Huntington's Disease (HD) {#S4.SS6}
-------------------------

Huntington's disease is an autosomal dominant, progressive, and neurodegenerative disease, with cognitive decline and defects in motor coordination. The cause of the disease is a CAG repeat expansion in the *HTT1* gene, encoding huntingtin, a ubiquitously expressed cytoplasmic protein. Mostly spiny projection neurons (SPNs) degenerate in HD, but it is not clearly known why mutant Huntington (mHTT) protein selectively targets these neurons ([@B17]). The function of wild type Huntingtin (wHTT) protein is not fully understood, but its multiple protein-protein interaction sites indicate that it might have a scaffolding role ([@B248]).

Disrupted Ca^2+^ signaling is also observed in HD disease models ([@B214]), suggesting that disordered Ca^2+^ handling makes SPNs more vulnerable to Ca^2+^-mediated cell death. Ca^2+^ disruption also causes aberrant synaptic plasticity ([@B144]). Binding of mHTT to IP3R increases receptor responsiveness to IP3, resulting in enhanced Ca^2+^ release ([@B351]), which may ultimately lead to apoptosis. The enhanced Ca^2+^ leak also depletes ER Ca^2+^ stores, triggering SOC replenishment of ER Ca^2+^ ([@B214]). This interaction between mHTT and IP3R might be a cause for neurodegeneration. Consistent with this, IP3R blockers prevent enhanced glutamate-mediated cell death in mouse striatal neurons ([@B350]), and in mouse neuronal cell culture. Moreover, IP3R knockdown prevents synapse loss, and inhibition of SOC channels rescues spine loss ([@B405]). Also, a repeat expansion in the gene encoding JPH3 associates to HD-like 2 ([@B150]), which phenocopies HD ([@B305]). JPH3 promotes ER-PM MCSs, controlling Ca^2+^ communication in hippocampal neurons ([@B235]). Therefore, ER roles in Ca^2+^ handling appear to be important for HD pathology and could present potential therapeutic targets.

Mutations in Vps13A are causative for chorea-acanthocytosis ([@B369]; [@B315]), a neurological syndrome with a HD-like phenotype ([@B170]). Since Vps13A is a lipid-transfer protein found at ER MCSs with mitochondria and LDs ([@B187]), this suggests lipid transfer between ER and other organelles as a primary vulnerability in the disease. However, Vps13A also mediates ER MCS tethering ([@B187]; [@B414]), and therefore Vps13A dysfunction could indirectly affect Ca^2+^ communication.

Peripheral Neuropathies and ER {#S4.SS7}
------------------------------

Peripheral neuropathies are a group of disorders characterized by injury or pathology in the peripheral nervous system ([@B46]). They are heterogenous, with a mix of genetic and acquired causes, clinical presentations, and pathologies. Patients can have motor insufficiency, sensory abnormalities, or both, depending on the disease. Mechanisms implicated in their pathologies include dysregulation of glucose pathway by hyperglycemia, dysfunction of mitochondria, reactive oxygen toxicity, impairments in inflammatory signaling pathways, axonal transport defects, and disrupted K^+^ and Na^+^ channels ([@B51]). In addition, dysfunctional ER can also contribute. For example, ER stress is one cause of some peripheral neuropathies ([@B324]; [@B212]; [@B162]). Dysfunctional SOC or ER-mitochondria MCSs, which in turn may produce ER stress, can also cause peripheral neuropathies. We will discuss the importance of smooth/tubular ER-associated processes, highlighting the critical role of disrupted Ca^2+^ homeostasis.

Charcot-Marie-Tooth disorder (CMT) \[also known as hereditary motor and sensory neuropathy (HMSN)\] is one of the most common inherited neurological disorders, with distal weakness and muscle atrophy, presenting with demyelination (CMT type 1) and axonal loss (CMT type 2) ([@B327]). CMT type 1A (CMT1A) is a peripheral neuropathy caused by duplications or mutations in peripheral myelin protein 22 (PMP22), a tetra-span membrane protein ([@B169]). These lead to demyelination, increased Schwann cell number and axonal loss, although the mechanisms that cause disease are not understood. Recently, it has been found that PMP22 controls Ca^2+^ homeostasis by interacting with the ER membrane protein STIM1, which results in increased Ca^2+^ influx through SOC channels ([@B376]). This supports an important role for ER Ca^2+^ in the pathogenesis of CMT1A, although any role disrupted by PMP mutations would likely be associated with Schwann cells and not with neuronal ER. The peripheral neuropathy CMT2A affects the peripheral and central nervous system, resulting in axon degeneration and progressive sensory loss in patients ([@B197]). CMT2A occurs as mostly autosomal dominant ([@B428]), but sometimes recessive ([@B161]) or semi-dominant ([@B271]) due to mutations in *MFN2*. As MFN2 localizes at both mitochondrial outer membrane and ER membrane, mediating tethering of both organelles ([@B71]), ER-mitochondria MCSs might be important in the molecular mechanism of CMT2A. In fact, the connectivity between ER and mitochondria correlates with the severity of the disease, and the reinforcement of these contacts prevents some axonal defects caused by MFN2 mutation ([@B26]; [@B190]). Neurons and fibroblasts cultured from patients carrying *MFN2* mutations show increased numbers of mitochondria in axons, which appear swollen and degenerating ([@B378]; [@B9]). Moreover, *MFN2* mutant iPSC-derived motor neurons, obtained from CMT2A patients, show disrupted mitochondrial trafficking and cytoskeletal arrangement like patients have, although the mitochondrial morphology is unaffected ([@B299]). Therefore, *MFN2* mutations might cause CMT2A pathogenesis through disrupting ER-mitochondria tethering and its functions. This is supported by other recent findings that altered ER-mitochondria MCSs leads to CMT axonopathy ([@B26]), and interestingly, increase of these contact sites promote axon regeneration ([@B195]). Together, this evidence suggests a critical role for ER Ca^2+^ in CMT, particularly in regulating mitochondrial function.

Other tubular ER-related proteins have also been linked to CMT pathologies. The junctophilin JPH1 mediates ER-PM tethering ([@B120]) and activates RyR channels to release Ca^2+^ from sarcoplasmic reticulum ([@B147]). Remarkably, its paralogues JPH3 and JPH4 enable functional coupling of PM Ca^2+^ channels with RyRs in the ER of hippocampal neurons ([@B235]; [@B294]). Deficiency of GADP1 (ganglioside-induced differentiation-associated protein 1), an outer mitochondrial membrane protein associated with CMT, affects Ca^2+^ homeostasis by reducing SOC ([@B273]). Interestingly, it has been reported that overexpression of *JPH1* rescues the SOC defects in *GADP1*-silenced cells, and that mutation of both *GADP1* and *JPH1* inhibits SOC activity. In fact, patients where these two genes are mutated show a more severe CMT than those where only *GADP1* is mutated ([@B272]). Another example is the ER chaperone SigR1, which modulates the Ca^2+^ release channels IP3R and STIM1 ([@B138]; [@B334]). Mutation in *SigR1* can result in CMT ([@B201]). In addition, mutation of *REEP1* can cause not only HSP, but also spinal CMT, affecting lower motor neurons ([@B20]). Mutation of the ER protein seipin is also associated with CMT as well as HSP ([@B15]). This protein mediates ER-LD tethering ([@B296], [@B297]), and gain-of-toxic-function mutation impairs synaptic neurotransmission ([@B395]).

Hereditary sensory neuropathies (HSNs) are neurological disorders characterized by degeneration of sensory neurons, with distal sensory loss in the lower limbs. HSNs are classified in eight phenotypically diverse types, which relate to specific genomic mutations and inheritance pattern ([@B310]). Mutations associated to HSNs affect functionally heterogeneous genes, making difficult to find a common pathway affected in patients ([@B290]). Several of the genes associated to the disease directly relate to the ER. Mutations in *FAM134B* can cause HSN type II, which shows autosomal recessive inheritance and manifests at early childhood. FAM134B is found at the *cis*-Golgi network, regulating the morphology of this structure ([@B188]), but also at the membrane of perinuclear ER, where acts as a ER-phagy receptor, mediating ER sequestration into autophagosomes ([@B174]). The most common HSN is HSN type I, presenting a progressive autosomal dominant pattern of inheritance and causing a slowly progressive neuronal degeneration ([@B310]). HSN type I can be caused by mutations in *SPTL1* or *SPTL2* genes, which respectively encodes for subunits 1 and 2 of the enzyme serine palmitoyltransferase (SPT). This enzyme is found at the ER membrane, and is required for the synthesis of sphingolipids ([@B210]), which present a key role in cell signal transduction ([@B136]). However, as for FAM134B, the current evidences do not support SPT distribution at axonal ER, and therefore, it remains unknown whether these proteins may have a role in axonal ER regulation. Other HSN type I-associated mutations affect the tubular ER-shaping proteins ATL1 ([@B128]) and ATL3 ([@B106]; [@B180]). The *ATL3* sensory neuropathy-causing mutation, *ATL3*^*Y192C*^, produces a less profuse ER network and prevents ATL localization at the axonal ER ([@B21]). Moreover, this mutation causes an increased number of ER-mitochondria MCSs, altering mitochondrial dynamics and distribution ([@B182]). This evidence suggests potential mechanisms by which defects in tubular ER may produce HSN.

Diabetic neuropathies are a type of neurodegenerative disease that mainly target sensory axons, autonomous axons and to some extent, motor axons ([@B104]). Common symptoms are numbness and paresthesia, and feet are affected earlier than hands more severely together with autonomic or motor neuropathies ([@B53]). ER-mitochondria MCSs play an essential role in diabetic neuropathies. They are regulated by glucose levels, acting as a nutrient sensor to switch between fat and glucose oxidation ([@B358]). High glucose levels disrupt both integrity and function of ER-mitochondria MCSs in hepatic cells, inducing mitochondrial fission and impaired respiration ([@B359]). This glucose-dependent regulation of ER-mitochondria MCSs is defective in the liver of insulin-resistant obese mice ([@B359]), which show increased ER-mitochondria MCSs, causing mitochondrial dysfunction through mitochondrial Ca^2+^ overload ([@B14]). Pancreatic beta-cells from patients with type 2 diabetes show reduced ER-mitochondria MCSs, and a similar effect is observed after fatty acid overload ([@B361]). Interestingly, ER-mitochondria MCSs are reduced in pro-opiomelanocortin neurons of diabetic mice, and reduction of ER-mitochondria MCSs in the same neurons, via ablation of *MFN2*, induces leptin resistance and obesity ([@B304]). In addition, type 1 diabetic rats show reduced ER Ca^2+^ content in DRG neurons, possibly due to decreased levels of the ER Ca^2+^ ATPase SERCA ([@B380]). Therefore, regulation of Ca^2+^ homeostasis through ER-Mitochondria MCSs is critical in diabetes pathogenesis, including the associated peripheral neuropathy. In rat cortical neurons rats, diabetes-induced neuritic dystrophy and cognitive dysfunction correlate with formation of aggregates of the tubular ER-shaping protein RTN3, similar to that observed in AD (see above). Aggregation of RTN3 prevents its inhibitory effect on BACE1, leading in turn to aggregation of amyloid β and diabetic dementia ([@B420]). However, it remains to be explored whether similar defects are associated with diabetes in peripheral nerves.

Human immunodeficiency virus (HIV)-associated sensory neuropathy commonly develops during HIV infection, characterized by numbness and hypersensitivity of the feet and lower legs, and above the knees in more severe cases ([@B218]). In primary DRG neurons, HIV coat protein gp120 causes axonal degeneration by inducing rapid large IP3-mediated Ca^2+^ release from ER. Decreasing ER Ca^2+^ storage promotes neuronal resistance to gp120-induced cell death ([@B149]), suggesting a crucial role for axonal ER.

Chemotherapy-induced peripheral neuropathy is a frequent side effect of chemotherapy ([@B416]). Dysregulation of Ca^2+^ homeostasis, where ER has a key role, contributes to the pain caused by chemotherapy-induced peripheral neuropathy ([@B328]). Ca^2+^ signaling from ER to mitochondria may have an important role, since a selective SigR1 antagonist reduces hypersensitivity and the proportion of patients developing severe chemotherapy-induced peripheral neuropathy ([@B44]).

Discussion {#S5}
==========

Neurodegeneration is a complex and multifactorial process causing progressive neurological diseases. The study of genes that influence these conditions provides information about the biology of neurons and their pathologies, and is a catalyst for development of therapeutic strategies. An increasing body of evidence implicates dysfunctional ER in many neurological disorders that affect axons. In rough ER, ER stress is caused by accumulation of misfolded/unfolded proteins, which activates UPR to restore homeostasis, but if not resolved, causes neuronal degeneration and death ([@B143]). However, axonal ER, which is mostly tubular and smooth and undertakes very little protein export, is also linked to neurodegeneration. Tubular ER is directly involved in the regulation of many cellular processes, such as lipid biosynthesis and degradation, Ca^2+^ signaling, or organelles and MT dynamics. In axons, ER forms a mostly tubular network that is pervasive and continuous, and in human axons up to 1 m in length, physically linking the cell body with presynaptic terminals. Therefore, neuronal cells are particularly vulnerable to suffer defects when tubular ER morphology or tubular ER MCSs goes wrong. Mutations in genes encoding both tubular ER-shaping proteins and proteins related with ER MCSs, are observed in patients with different disorders (i.e., HSP, CMT, WRBM, PD, AD) ([Table 2](#T2){ref-type="table"}), where different types of neurons are preferentially affected. Interestingly, mutations affecting ER morphology may indirectly cause altered ER MCSs, potentially explaining why mutations in genes related to either ER morphology or ER MCSs produce similar neuronal defects. The pervasive and continuous nature of the ER suggests an important role for tubular ER continuity and/or local presence in axons. Evidence also suggests a critical role for ER Ca^2+^, particularly in regulating mitochondrial function. Defects in ER Ca^2+^ handling are associated with the pathogenic mechanisms of different neurological diseases ([Table 2](#T2){ref-type="table"}), and some of these ER Ca^2+^ defects relate to ER-mitochondria MCSs.

Tubular ER shows a highly dynamic nature, and the transport of ER tubules depends on the MT network. Therefore, it is not surprising that long cells, as neurons are, appear preferentially affected in patients with mutations in genes related with tubular ER dynamics. Therefore, proper axonal ER dynamics (including ER MCSs) and transport may be crucial to managing local changes/responses within the neuron.

Axonal ER has been largely neglected as an organelle since its early characterization around four decades ago. We are only starting to learn about its biological importance, and there is growing evidence for it as a potential site of pathology, and hence a potential therapeutic target, particularly for neurological disorders that affect distal longer axons. The preferential susceptibility of distal axons to disease-causing mutations in ER-shaping proteins points to functional importance of its specialized architecture. Exciting areas for study in the coming years include both the mechanisms that adapt the dynamic tubular ER network to the dimensions of axons -- its physical continuity, narrow lumen, density of tubules in the cytosol -- and the physiological roles of these architectural features, and how impairment of these functions can lead to degeneration. The genetics of the HSP diseases has opened windows both on possible disease mechanisms, and a fascinating area of basic biology. Understanding the basic biology of axonal ER will lead to new insights on the mechanisms of axon degeneration, and conversely understanding the disease mechanisms will lead to new insights in basic biology of axonal ER. Studies of the basic cell biology and the disease mechanisms will feed each other over the coming years.
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